[go: up one dir, main page]

FR11C0050I2 - RECOMBINANT MYXOMATOUS VIRUS - Google Patents

RECOMBINANT MYXOMATOUS VIRUS

Info

Publication number
FR11C0050I2
FR11C0050I2 FR11C0050C FR11C0050C FR11C0050I2 FR 11C0050 I2 FR11C0050 I2 FR 11C0050I2 FR 11C0050 C FR11C0050 C FR 11C0050C FR 11C0050 C FR11C0050 C FR 11C0050C FR 11C0050 I2 FR11C0050 I2 FR 11C0050I2
Authority
FR
France
Prior art keywords
myxomatous
recombinant
virus
recombinant myxomatous
myxomatous virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR11C0050C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ecole Nat Veterinaire De Toulouse Envt
Institut National de la Recherche Agronomique INRA
Ecole Nationale Veterinaire de Toulouse ENVT
Original Assignee
Ecole Nat Veterinaire De Toulouse Envt
Institut National de la Recherche Agronomique INRA
Ecole Nationale Veterinaire de Toulouse ENVT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecole Nat Veterinaire De Toulouse Envt, Institut National de la Recherche Agronomique INRA, Ecole Nationale Veterinaire de Toulouse ENVT filed Critical Ecole Nat Veterinaire De Toulouse Envt
Publication of FR11C0050I1 publication Critical patent/FR11C0050I1/fr
Application granted granted Critical
Publication of FR11C0050I2 publication Critical patent/FR11C0050I2/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR11C0050C 1995-07-05 2011-11-15 RECOMBINANT MYXOMATOUS VIRUS Active FR11C0050I2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9508128A FR2736358B1 (en) 1995-07-05 1995-07-05 RECOMBINANT MYXOMATOUS VIRUS

Publications (2)

Publication Number Publication Date
FR11C0050I1 FR11C0050I1 (en) 2011-12-16
FR11C0050I2 true FR11C0050I2 (en) 2012-06-22

Family

ID=9480712

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9508128A Expired - Lifetime FR2736358B1 (en) 1995-07-05 1995-07-05 RECOMBINANT MYXOMATOUS VIRUS
FR11C0050C Active FR11C0050I2 (en) 1995-07-05 2011-11-15 RECOMBINANT MYXOMATOUS VIRUS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR9508128A Expired - Lifetime FR2736358B1 (en) 1995-07-05 1995-07-05 RECOMBINANT MYXOMATOUS VIRUS

Country Status (4)

Country Link
DE (1) DE19627193B4 (en)
ES (1) ES2113322B1 (en)
FR (2) FR2736358B1 (en)
IT (1) IT1286307B1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2153284B1 (en) * 1998-06-10 2001-09-01 Fundacion Para El Estudio Y De NEW RECOMBINANT VIRUS OF ATTENATED MIXOMA AND ITS USE IN THE PREPARATION OF MIXED VACCINES AGAINST MIXOMATOSIS AND HEMORRAGICAL DISEASE OF THE RABBITS.
DE60209345T2 (en) * 2001-03-08 2006-08-03 Akzo Nobel N.V. LEPORIPOX-BASED VECTOR VACCINE
FR2946536B1 (en) * 2009-06-11 2011-07-29 Agronomique Inst Nat Rech USE OF AN ATXURATED STRAIN OF MYXOMA VIRUS AS AN ONCOLYTIC
AU2016313969B2 (en) 2015-06-19 2021-12-23 Sillajen, Inc. Compositions and methods for viral embolization

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869312A (en) * 1992-01-13 1999-02-09 Syntro Corporation Recombinant swinepox virus

Also Published As

Publication number Publication date
IT1286307B1 (en) 1998-07-08
FR2736358A1 (en) 1997-01-10
DE19627193A1 (en) 1997-03-20
FR11C0050I1 (en) 2011-12-16
ES2113322A1 (en) 1998-04-16
ITTO960578A0 (en) 1996-07-05
ES2113322B1 (en) 1998-12-01
DE19627193B4 (en) 2007-08-30
FR2736358B1 (en) 1997-09-26
ITTO960578A1 (en) 1998-01-05

Similar Documents

Publication Publication Date Title
NO2010013I1 (en) Recombinant FSH-CTP
DK0736303T3 (en) interferon
DK0809996T3 (en) interferon
TR199600084A2 (en) Proteins against blistering.
ATE209045T1 (en) HEPATITIS B VACCINE
FI961350L (en) Hapten-tagged peptides
DE59604011D1 (en) oven
DE69606628D1 (en) OVEN
DE69829373D1 (en) Polymerization
NO976058L (en) Recombinant Mistakine
DE69813694D1 (en) polymerization
BR9610239A (en) Xcd32-allergen-fusion proteins
FI972030A0 (en) Purified papillomavirus proteins
FI970168L (en) Peptides
DE69608637D1 (en) Magnetron
FR11C0050I2 (en) RECOMBINANT MYXOMATOUS VIRUS
FI964363L (en) Peptides
DE69839129D1 (en) Polymerization
IS4629A (en) Linked viral nucleic acids
DE59503694D1 (en) oven
EP0821694A4 (en) CONOTOXIN PEPTIDES
DE69826832D1 (en) Polymerization
DE59601829D1 (en) OVEN
FI944558A0 (en) Virus
ITMI950511A0 (en) IMPROVED PARALLEL PHOTODENSITOMETER